ABF Pharmaceutical Services classified as "critical infrastructure" by the Federal Chancellery
Press Release
Security of supply during the coronavirus crisis: ABF Pharmaceutical Services classified as "critical infrastructure" by the Federal Chancellery
"The classification of our company as a ‘critical infrastructure’ is very important for our business partners in the pharmaceutical and biotech industry as well as for patients and doctors, especially during the current coronavirus crisis. This is because the classification ensures that our operations can continue even in the event of a complete shutdown of the economy and that we thus would be able to continue to fulfill our mandate to supply drugs critical to human health," said Dr Elisabeth Lackner, Chief Executive Officer of ABF Pharmaceutical Services and GBA Group Pharma.